Načítá se...
A118 FECAL CALPROTECTIN COMPLETION RATES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
BACKGROUND: Fecal Calprotectin (FC) is a biomarker that has been shown to be sensitive and specific for mucosal inflammation in Inflammatory Bowel Disease (IBD). FC is useful to monitor disease activity and response to therapy in patients with IBD. Unfortunately, several factors contribute to a fair...
Uloženo v:
| Vydáno v: | J Can Assoc Gastroenterol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512595/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.117 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|